Cargando…

Vaccine‐preventable disease hospitalized patients with heart failure with reduced ejection fraction

BACKGROUND: Over five million Americans suffer from heart failure (HF), and this is associated with multiple chronic comorbidities and recurrent decompensation. Currently, there is an increased incidence in vaccine‐preventable diseases (VPDs). We aim to investigate the impact of HF with reduced ejec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Del Cid Fratti, Juan, Salazar, Miguel, Argueta‐Sosa, Erwin E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Clinical Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045068/ https://www.ncbi.nlm.nih.gov/pubmed/35266175 http://dx.doi.org/10.1002/clc.23800

Ejemplares similares

Association of muscular fitness with rehospitalization for heart failure with reduced ejection fraction
por: Lee, Chan Joo, et al.
Publicado: (2020)

Respiratory support in acute heart failure with preserved vs reduced ejection fraction
por: Metkus, Thomas S., et al.
Publicado: (2019)

The concentration of interleukin-33 in heart failure with reduced ejection fraction
por: Anna Segiet, Oliwia, et al.
Publicado: (2019)

Reduced Lymphatic Reserve in Heart Failure With Preserved Ejection Fraction
por: Rossitto, Giacomo, et al.
Publicado: (2020)

Association between right heart catheterization hemodynamics and glycosylated hemoglobin levels in adults with heart failure with reduced ejection fraction
por: Del Rio-Pertuz, Gaspar, et al.
Publicado: (2023)

Diastolic function is associated with quality of life and exercise capacity in stable heart failure patients with reduced ejection fraction
por: Bussoni, M.F., et al.
Publicado: (2013)

Tailored risk assessment of 90‐day acute heart failure readmission or all‐cause death to heart failure with preserved versus reduced ejection fraction
por: Park, Jaeyoung, et al.
Publicado: (2022)

The prognostic value of altitude in patients with heart failure with reduced ejection fraction
por: Kaya, Ahmet, et al.
Publicado: (2019)

Cost-effectiveness of Dapagliflozin for the Treatment of Heart Failure With Reduced Ejection Fraction
por: Isaza, Nicolas, et al.
Publicado: (2021)

Twist/untwist parameters are promising evaluators of myocardial mechanic changes in heart failure patients with preserved ejection fraction
por: Zhang, Yi, et al.
Publicado: (2020)

Long‐term results of combined cardiac contractility modulation and subcutaneous defibrillator therapy in patients with heart failure and reduced ejection fraction
por: Röger, Susanne, et al.
Publicado: (2018)

Effect of melatonin supplementation on endothelial function in heart failure with reduced ejection fraction: A randomized, double‐blinded clinical trial
por: Hoseini, Shervin Ghaffari, et al.
Publicado: (2021)

Usefulness of urinary potassium to creatinine ratio to predict diuretic response in patients with acute heart failure and preserved ejection fraction
por: Llàcer, Pau, et al.
Publicado: (2023)

Correlation analysis of the triglyceride glucose index and heart failure with preserved ejection fraction in essential hypertensive patients
por: Liao, Li Ping, et al.
Publicado: (2022)

Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction: A meta‐analysis
por: Gu, Gaoyang, et al.
Publicado: (2022)

The predictive value of changes in left atrial volume index for rehospitalization in heart failure with preserved ejection fraction
por: Hao, Zhujing, et al.
Publicado: (2022)

Narrative review: the holy grail: update on pharmacotherapy for heart failure with preserved ejection fraction
por: Paz, Pablo Alejandro, et al.
Publicado: (2021)

Relationship Between Urinary Angiotensinogen and Mortality in Patients with Heart Failure with Reduced Ejection Fraction
por: Örsçelik, Özcan, et al.
Publicado: (2023)

Ventricular arrhythmias not meeting criteria for terminating cardiopulmonary exercise testing stratify prognosis and disease severity in heart failure of preserved, midrange, and reduced ejection fraction
por: Popovic, Dejana, et al.
Publicado: (2020)

Mode of Death Among Japanese Adults With Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction
por: Kitai, Takeshi, et al.
Publicado: (2020)

Subclinical Risk Factors for Heart Failure With Preserved and Reduced Ejection Fraction Among Black Adults
por: Zhao, Li, et al.
Publicado: (2022)

Sildenafil and Kidney Function in Heart Failure with Preserved Ejection Fraction
por: Edmonston, Daniel, et al.
Publicado: (2023)

Ejection fraction, B‐type natriuretic peptide and risk of stroke and acute myocardial infarction among patients with heart failure
por: Greenberg, Barry, et al.
Publicado: (2019)

Anticoagulants for stroke prevention in heart failure with reduced ejection fraction
por: Schäfer, Andreas, et al.
Publicado: (2021)

Association Between Preexisting Heart Failure With Reduced Ejection Fraction and Fluid Administration Among Patients With Sepsis
por: Powell, Rachel E., et al.
Publicado: (2022)

Optimal Pharmacologic Treatment of Heart Failure With Preserved and Mildly Reduced Ejection Fraction: A Meta-analysis
por: Xiang, Boyang, et al.
Publicado: (2022)

Safety and Tolerability of Nicotinamide Riboside in Heart Failure With Reduced Ejection Fraction
por: Wang, Dennis D., et al.
Publicado: (2022)

Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction
por: Liu, Dan, et al.
Publicado: (2023)

The impact of heart rate on patients diagnosed with heart failure with mid-range ejection fraction
por: Xin, Yanguo, et al.
Publicado: (2019)

MYOPERICARDITIS AND HEART FAILURE WITH REDUCED EJECTION FRACTION FOLLOWING SECOND DOSE OF MRNA COVID-19 VACCINE
por: Cole, Molly, et al.
Publicado: (2023)

Vericiguat for Heart Failure with Reduced Ejection Fraction
por: Lombardi, Carlo Mario, et al.
Publicado: (2021)

Management of heart failure with reduced ejection fraction
por: Haydock, Paul M, et al.
Publicado: (2022)

Relationship between intrarenal renin-angiotensin activity and re-hospitalization in patients with heart failure with reduced ejection fraction
por: Örsçelik, Özcan, et al.
Publicado: (2018)

Load-independent effects of empagliflozin contribute to improved cardiac function in experimental heart failure with reduced ejection fraction
por: Connelly, Kim A., et al.
Publicado: (2020)

Prognostic Value of Anxiety Between Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection Fraction
por: Lin, Tin‐Kwang, et al.
Publicado: (2019)

Importance of epicardial adipose tissue localization using cardiac magnetic resonance imaging in patients with heart failure with mid‐range and preserved ejection fraction
por: van Woerden, Gijs, et al.
Publicado: (2021)

Effect of Dapagliflozin on Total Heart Failure Events in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the DELIVER Trial
por: Jhund, Pardeep S., et al.
Publicado: (2023)

NEW-ONSET HEART FAILURE WITH REDUCED EJECTION FRACTION IN PATIENTS WITH COVID-19
por: Rai, Nanak S., et al.
Publicado: (2023)

Primary care heart failure service identifies a missed cohort of heart failure patients with reduced ejection fraction
por: Kahn, Matthew, et al.
Publicado: (2021)

Adherence to guideline-directed medical and device Therapy in outpAtients with heart failure with reduced ejection fraction: The ATA study
por: Kocabaş, Umut, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ek2npi6na442nqakaf731t4fm2